Founded in 1998, Gan & Lee Pharmaceuticals is a leading biopharmaceutical company in China specializing in the development, production, and commercialization of insulin analogs and supporting medical devices. Headquartered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters and nearly 3000 employees. With state-of-the-art buildings and GMP facilities, Gan & Lee has become one of the main suppliers of insulin in China and now strives to broaden its global coverage in the field of diabetes diagnosis and treatment.
